Background: There are limited data on short- versus long-term changes in adaptive immune response across different COVID-19 disease severity groups.
Methods: A multicenter prospective study of 140 adult patients with COVID-19 (a total of 325 samples) were analyzed for inflammatory markers and lymphocyte subsets at presentation, week 2, and week 24.
Results: Inflammatory markers at presentation were higher in the critical/severe than in moderate and mild groups.
High-grade epithelial ovarian cancer is a fatal disease in women frequently associated with drug resistance and poor outcomes. We previously demonstrated that a marine-derived compound MalforminA1 (MA1) was cytotoxic for the breast cancer cell line MCF-7. In this study, we aimed to examine the effect of MA1 on human ovarian cancer cells.
View Article and Find Full Text PDF